4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000066
President and CEO sold 1,000 shares at $15.00 ($15,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doshi Dipal President and CEO | 2023-09-13 | Sale 10b5-1 | −1,000 | $15.00 | $15,000 | 248,279 | D: show line 1 in the form |
| Open-market sales · 1,000 sh · avg $15.00 · $15,000 | |||||||
Loading xslF345X05/wf-form4_169480928381353.xml…